References
Moncada S, Higgs A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002–2012.
Bredt DS, Snyder SH. (1994) Nitric oxide: a physiologic messenger molecule. Annu. Rev. Biochem. 63: 175–195.
Clancy RM, Abramson SB. (1995) Nitric oxide—a novel mediator of inflammation [Review]. Proc. Soc. Exp. Biol. Med. 210: 93–101.
Michel T, Feron O. (1997) Nitric oxide synthases—which, where, how, and why. J. Clin. Invest. 100: 2146–2152.
Nathan C, Xie QW. (1994) Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269: 13725–13728.
Macmicking J, Xie QW, Nathan C. (1997) Nitric oxide and macrophage function [Review]. Annu. Rev. Immunol. 15: 323–350.
Gross SS, Levi R. (1992) Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J. Biol. Chem. 267: 25722–25729.
Rosenkranz-Weiss P, Sessa WC, Milstien S, et al. (1994) Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest. 93: 2236–2243.
Nathan C. (1994) Nitric oxide and biopterin: a study in chiaroscuro. J. Clin. Invest. 93: 1875–1876.
Assreuy J, Cunha FQ, Liew FY, Moncada S. (1993) Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 108: 833–837.
Rogers NE, Ignarro LJ. (1992) Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem. Biophys. Res. Commun. 189: 242.
Albina JE. (1995) On the expression of nitric oxide synthase by human macrophages—why no NO [Review]. J. Leukoc. Biol 58: 643–649.
Denis M. (1994) Human monocytes/macrophages: NO or no NO? J. Leukoc. Biol. 55: 682–684.
Ochoa JB, Curti B, Peitzman AB, et al. (1992) Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes [published erratum appears in J. Natl. Cancer Inst. (1992) 84: 12991]. J. Natl. Cancer Inst. 84: 864–867.
Hibbs JB, Jr, Westenfelder C, Taintor R, et al. (1992) Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy [published erratum appears in J. Clin Invest. (1992) 90: 295]. J. Clin. Invest. 89: 867–877.
Green LC, de Luzuriaga KR, Wagner DA, et al. (1981) Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. U.S.A. 78: 7764–7768.
Ochoa JB, Udekwu AO, Billiar TR, et al. (1991) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351: 265–266.
Kun JFJ, Mordmuller B, Lell B, et al. (1998) Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Lancet 351: 265–266.
Feelisch M, Stamler JS. (1996) Methods in Nitric Oxide Research. John Wiley & Sons, Chichester.
Stamler JS, Singel DJ, Loscalzo J. (1992) Biochemistry of nitric oxide and its redox-activated forms. [Review]. Science 258: 1898–1902.
Green LC, Wagner DA, Glogowski J, et al. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 126: 131–138.
Granger DL, Taintor RR, Boockvar KS, Hibbs JB, Jr. (1995) Determination of nitrate and nitrite in biological samples using bacterial nitrate reductase coupled with the Griess reaction. Methods: A Companion to Methods Enzymol 7: 78–83.
Beckman JS, Chen J, Ischiropoulos H, Crow JP. (1994) Oxidative chemistry of peroxynitrite. Methods Enzymol. 233: 229–240.
Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. (1994) Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79: 1137–1146.
Mannick JB, Miao XQ, Stamler JS. (1997) Nitric oxide inhibits Fas-induced apoptosis. J. Biol Chem. 272: 24125–24128.
Reiling N, Kroncke R, Ulmer AJ, et al. (1996) Nitric oxide synthase—expression of the endothelial, Ca2+/calmodulin-dependent in human B and T lymphocytes. Eur. J. Immunol 26: 511–516.
Chen LY, Metha JL. (1996) Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J. Cardiovasc. Pharmacol. 27: 154–158.
Radomski MW, Palmer RM, Moncada S. (1990) Characterization of the L-arginine:nitric oxide pathway in human platelets. Br. J. Pharmacol. 101: 325–328.
Malinski T, Radomski MW, Taha Z, Moncada S. (1993) Direct electrochemical measurement of nitric oxide released from human platelets. Biochem. Biophys. Res. Commun. 194: 960–965.
Weinberg JB, Misukonis MA, Shami PJ, et al. (1995) Human mononuclear phagocyte inducible nitric oxide synthase (iNOS). Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86: 1184–1195.
Salvemini D, de Nucci G, Gryglewski RJ, Vane JR. (1989) Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc. Natl Acad. Sci. U.S.A. 86: 6328–6332.
Hunt NC, Goldin RD, (1992) Nitric oxide production by monocytes in alcoholic liver disease. J. Hepatol 14: 146–150.
Middleton SJ, Cuthbert AW, Shorthouse M, Hunter JO. (1993) Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition. Br. J. Pharmacol. 108: 974–979.
Martin JH, Edwards SW. (1993) Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing. J. Immunol. 150: 3478–3486.
Wickramasinghe SN, Hasan R. (1993) Possible role of macrophages in the pathogenesis of ethanol-induced bone marrow damage. Br. J. Haematol. 83: 574–579.
Petit JF, Phan-Bich L, Lemaire G, Martinache C, Lopez M. (1993) During their differentiation into macrophages, human monocytes acquire cytostatic activity independent of NO and TNF alpha. Res. Immunol. 144: 277–280; discussion 2994–298.
Chu SC, Wu HP, Banks TC, Eissa NT, Moss J. (1995) Structural diversity in the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J. Biol. Chem. 270: 10625–10630.
Eissa NT, Strauss AJ, Haggerty CM, et al. (1996) Alternative splicing of human inducible nitricoxide synthase mRNA. Tissue-specific regulation and induction by cytokines. J. Biol. Chem. 271: 27184–27187.
Granger DL, Hibbs JB, Jr, Perfect JR, Durack DT. (1988) Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J. Clin. Invest. 81: 1129–1136.
Cameron ML, Granger DL, Weinberg JB, Kozumbo WJ, Koren HS. (1990) Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am. Rev. Respir. Dis. 142: 1313–1319.
Denis M. (1991) Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukoc. Biol. 49: 380–387.
Sherman MP, Loro ML, Wong VZ, Tashkin DP. (1991) Cytokine-and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J. Protozool. 38: 234S–236S.
Muñoz-Fernández MA, Fernández MA, Fresno M. (1992) Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol. Lett. 33: 35–40.
Harwix S, Andreesen R, Ferber E, Schwamberger G. (1992) Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-α and reactive nitrogen intermediates. Res. Immunol. 143: 89–94.
Murray HW, Teitelbaum RF. (1992) L-argininereactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 165: 513–517.
Padgett EL, Pruett SB. (1992) Evaluation of nitrite production by human monocyte-derived macrophages. Biochem. Biophys. Res. Commun. 286: 775–781.
Ben-Efraim S, Tak C, Fieren MJWA, et al. (1993) Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-α, PGE2 and nitrite, in vitro studies. Immunol. Lett. 37: 27–33.
Bermudez LE. (1993) Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin. Exp. Immunol. 91: 277–281.
Keller R, Keist R, Joller P, Groscurth P. (1993) Mononuclear phagocytes from human bone marrow progenitor cells; morphology, surface phenotype, and functional properties and activated cells. Clin. Exp. Immunol. 91: 176–182.
Sakai N, Milstien S. (1993) Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages. Biochem. Biophys. Res. Commun. 193: 378–383.
Schneemann M, Schoedon G, Hofer S, et al. (1993) Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167: 1358–1363.
Barnewall RE, Rikihisa Y. (1994) Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect. Immun. 62: 4804–4810.
Essery SD, Saadi AT, Twite SJ, et al. (1994) Lewis antigen expression on human monocytes and binding of pyrogenic toxins. Agents Actions 41: 108–110.
Gyan B, Troye-Blomberg M, Perlmann P, Bjorkman A. (1994) Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasite Immunol. 16: 371–375.
Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch ARE. (1994) Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc. Natl. Acad. Sci. U.S.A. 91: 4190–4194.
Martin JH, Edwards SW. (1994) Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production. Immunology 81: 592–597.
Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J. (1994) Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur. J. Immunol. 24: 435–439.
Siedlar M, Marcinkiewicz M, Zembala M. (1995) MHC class I and class II determinants and some adhesion molecules are engaged in the regulation of nitric oxide production in vitro by human monocytes stimulated with colon carcinoma cells. Clin. Immunol. Immunopathol. 77: 380–384.
Bose M, Farnia P. (1995) Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process. Immunol Lett. 48: 59–64.
Reiling N, Ulmer AJ, Duchrow M, et al. (1994) Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur. J. Immunol. 24: 1941–1944.
Bukrinsky MI, Nottet H, Schmidt-Mayerova H, et al. (1995) Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes—implications for HIV-associated neurological disease. J. Exp. Med. 181: 735–745.
Bagasra O, Bobroski L, Sarker A, et al. (1997) Absence of the inducible form of nitric oxide synthase in the brains of patients with the acquired immunodeficiency syndrome. J. Neurovirol. 3: 153–167.
Liu J, Zhao ML, Brosnan CF, Lee SC. (1996) Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of Il-1 beta and IL-1 receptor antagonist. J. Immunol. 157: 3569–3576.
Zinetti M, Fantuzzi G, Delgado R, et al. (1995) Endogenous nitric oxide production by human monocyte cells regulates LPS-induced TNF production. Eur. Cytokine Network 6: 45–48.
Condino-Neto A, Muscara MN, Bellinatipires R, et al. (1996) Effect of therapy with recombinant human interferon-gamma on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease. J. Interferon. Cytokine Res. 16: 357–364.
Kashem A, Endoh M, Yano N, et al. (1996) Expression of inducible-NOS in human glomerulonephritis—the possible source is infiltrating monocytes/macrophages. Kidney Int. 50: 392–399.
St. Clair EW, Wilkinson WE, Lang T, et al. (1996) Increased expression of blood mononuclear cell nitric oxide synthase type 2 in the rheumatoid arthritis patients. J. Exp. Med. 184: 1173–1178.
Wang CL, Su MH, Chao TY, Shaio Mf, Yang KD. (1996) When do human macrophages release nitric oxide? Variable effects of certain in vitro cultural and in vivo resident conditions. Proc. Natl. Sci. Counc. Repub. China B 20: 65–70.
Amin AR, Attur M, Vyas P, et al. (1997) Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils. J. Inflam. 47: 190–205.
Polack B, Pernod G, Barro C, Doussiere J. (1997) Role of oxygen radicals in tissue factor induction by endotoxin in blood monocytes. Haemostasis 27: 193–200.
Saha DC, Astiz ME, Lin RY, Rackow EC, Eales LJ. (1997) Monophosphoryl lipid A stimulated upregulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro. Immunopharmacology 37: 175–184.
Snell JC, Chernyshev O, Gilbert DL, Colton CA. (1997) Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages. J. Leukoc. Biol. 62: 369–373.
Ding AH, Nathan CF, Stuehr DJ. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407–24112.
Zhou AQ, Chen ZF, Rummage JA, et al. (1995) Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase. J. Interferon Cytokine Res. 15: 897–904.
Diefenbach A, Schindler H, Donhauser N, et al. (1998) Type 1 interferon (IFN-alpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8: 77–87.
Sharara AI, Perkins DJ, Misukonis MA, et al. (1997) Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression—possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo. J. Exp. Med. 186: 1495–1502.
Vial T, Descotes J. (1995) Immune-mediated side-effects of cytokines in humans. Toxicology 105: 32–57.
Levesque MC, Ward FE, Jeffery DR, Weinberg JB. (1998) Interferon beta-la induced polyarthritis in a patient with the HLA-DRB1 *0404 allele. Arth. Rheum. In press.
Kolb JP, Paul-Eugene N, Damais C, et al. (1994) Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. Involvement of the nitric oxide synthase pathway. J. Biol. Chem. 269: 9811–9816.
Mautino G, Paul-Eugene N, Chanez P, et al. (1994) Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J. Leukoc. Biol. 56: 15–20.
Paul-Eugene N, Kolb JP, Damais C, Yamaoka K, Dugas B. (1994) Regulatory role of nitric oxide in the IL-4-induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 13: 287–293.
Lecoanet-Henchoz S, Gauchat JF, Aubry JP, et al. (1995) CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-Cd18 and CD11c-CD18. Immunity 3: 199–125.
Paul-Eugene N, Kolb JP, Sarfati M, et al. (1995) Ligation of CD23 activated soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism. J. Leukoc. Biol. 57: 160–167.
Paul-Eugene N, Pene J, Bousquet J, Dugas B. (1995) Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine 7: 64–69.
Paul-Eugene N, Mossalayi D, Sarfati M, et al. (1995) Evidence for a role of Fc epsilon RII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell. Immunol. 163: 314–318.
Dugas N, Vouldoukis L, Becherel P, et al. (1996) Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages. Eur. J. Immunol. 26: 1394–1398.
Vouldoukis I, Riverosmoreno V, Dugas V, et al. (1995) The killing of leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc-epsilon-RII/Cd23 surface antigen. Proc. Natl. Acad. Sci. U.S.A. 92: 7804–7808.
Aubry JP, Dugas N, Lecoanet-Henchoz S, et al. (1997) The 25-Kda soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J. Immunol. 159: 614–622.
Vouldoukis I, Becherel PA, Riverosmoreno V, et al. (1997) Interleukin-10 and interleukin-4 inhibit intracellular killing of leishmania infantum and leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol 27: 860–865.
Schneemann M, Schoedon G, Linscheid P, et al. (1997) Nitrite generation in interleukin-4-treated human macrophage cultures does not involved the nitric oxide synthase pathway. J. infect. Dis. 175: 130–135.
Dumarey CH, Labrousse V, Rastogi N, Vargaftig BB, Bachelet M. (1994) Selective Mycobacterium avium-induced production of nitric oxide by human monocyte-derived macrophages. J. Leukoc. Biol 56: 36–40.
Naotunne TS, Karunaweera ND, Mendis KN, Carter R. (1994) Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Immunology 78: 555–562.
Seitzer U, Scheeltoellner D, Toellner KM, et al. (1997) Properties of multinucleated giant cells in a new in vitro model for human granuloma formation. J. Pathol 182: 99–105.
Pietraforte D, Tritarelli E, Testa U, Minetti M. (1994) gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J. Leukoc. Biol 55: 175–182.
Tufano MA, Rossano F, Catalanotti P, et al. (1994) Properties of Yersinia enterocolitica porins: interference with biological functions of phagocytes, nitric oxide production and selective cytokine release. Res. Microbiol. 145: 297–307.
Belenky SN, Robbins RA, Rubinstein I. (1993) Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J. Leukoc. Biol. 53: 498–503.
De Maria R, Cifone MG, Trotta R, et al. (1994) Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180: 1999–2004.
Perez-Mediavilla LA, Lopez-Zabalza MJ, Calonge M, et al. (1995) Inducible nitric oxide synthase in human lymphomononuclear cells activated by synthetic peptides derived from extracellular matrix proteins. FEBS Lett. 357: 121–124.
McLachlan JA, Serkin CD, Bakouche O. (1996) Dehydroepiandrosterone modulation of lipopo-lysaccharide-stimulated monocyte cytotoxicity. J. Immunol 156: 328–335.
Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB. (1996) Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J. Immunol. 156: 4845–4850.
Aymerich MS, Bengoecheaalonso MT, Lopezzabalza MJ, Santiago E, Lopezmoratalla N. (1998) Inducible nitric oxide synthase (iNOS) expression in human monocytes triggered by beta-endorphin through an increase in cAMP. Biochem. Biophys. Res. Commun. 245: 717–721.
Stefano GB, Liu Y, Goligorsky MS. (1996) Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes microglia, and human monocytes. J. Biol. Chem. 271: 19238–19242.
King JM, Srivastava KD, Stefano GB, et al. (1997) Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J. Immunol 158: 880–886.
Lammas DA, Stober C, Harvey CJ, et al. (1997) ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2ZP2X(7)) receptors. Immunity 7: 433–444.
Vitek MP, Snell J, Dawson H, Colton CA. (1997) Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide. Biochem. Biophys. Res. Commun. 240: 391–394.
Criado-Jimenez M, Rivas-Cabanero L, Martin-Oterino JA, Lopez-Novoa JM, Sanchez-Rodriguez A. (1995) Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis. J. Mol. med. 73: 31–33.
Laffi G, Foschi M, Masini E, et al. (1995) Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. Hepatology 22: 1666–1673.
Masini E, Mugnai L, Foschi M, et al. (1995) Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. Int. Arch. Allergy Immunol. 107: 197–198.
Majano PL, García-Monzón C, López-Cabrera M, et al. (1998) Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. J. Clin. Invest. 101: 1343–1352.
Majano PL, Garciamonzon C, Lopezcabrera M, et al. (1998) Inducible nitric oxide synthase expression in chronic viral hepatitis. J. Clin. Invest. 101: 1343–1352.
Kobzik L, Bredt DS, Lowenstein CJ, et al. (1993) Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell. Mol. Biol. 9: 371–377.
Tracey WR, Xue C, Klinghofer V, et al. (1994) immunochemical detection of inducible NO synthase in human lung. Am. J. Physiol. 266: L722–L727.
Haddad IY, Pataki G, Hu P, et al. (1994) Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94: 2407–2413.
Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. (1995) Evidence for in vivo peroxynitrite production in human acute lung injury. Am. J. Respir. Crit. Care Med. 151: 1250–1254.
McDermott CD, Gavita SM, Shennib H, Giaid A. (1997) Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis. Transplantation 64: 270–274.
Nozaki Y, Hasegawa Y, Ichiyama S, Nakashima I, Shimokata K. (1997) Mechanism of nitric oxide-dependent killing of mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65: 3544–3647.
Kumar V, Jindal SK, Ganguly NK. (1995) Release of reactive oxygen and nitrogen intermediates from monocytes of patients with pulmonary tuberculosis. Scand. J. Clin. Lab. Invest. 55: 163–169.
Nicholson S, Bonecinialmeida MDG, Silva LE, Jr, et al. (1996) Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183: 2293–2302.
Tunctan B, Okur H, Calisir CH, et al. (1998) Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis. Pharmacol. Res. 37: 219–226.
Wang CH, Liu CY, Lin HC, et al. (1998) Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in Alveolar macrophages. Eur. Respir. J. 11: 809–815.
Beckman JS, Ye YZ, Anderson PG, et al. (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohisto-chemistry. Biol. Chem. Hoppe-Seyler 375: 81–88.
Buttery LDK, Springall DR, Chester AH, et al. (1996) Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab. Invest. 75: 77–85.
Wilcox JN, Subramanian RR, Sundell CL, et al. (1997) Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17: 2479–2488.
Luoma JS, Stralin P, Marklund SL, et al. (1998) Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions—colocalization with epitopes characteristics oxidized LDL and peroxynitrite-modified proteins. Arterioscler. Thromb. Vasc. Biol. 18: 157–167.
Lafond-Walker A, Chen CL, Augustine S, et al. (1997) Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis. Am. J. Pathol. 151: 919–925.
Wildhirt SM, Dudek RR, Suzuki H, Bing RJ. (1995) Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction. Int. J. Cardiol. 50: 253–261.
Weyand CM, Wagner AD, Bjornsson J, Goronzy JJ. (1996) Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J. Clin. Invest. 98: 1642–1649.
Sakurai H, Kohsaka H, Liu MF, et al. (1995) Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96: 2357–2363.
McInnes LB, Leung BP, Field M, et al. (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 184: 1519–1524.
Grabowski PS, Wright PK, Vanthof RJ, et al. (1997) Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br. J. Rheumatol. 36: 651–655.
Perkins DJ, St. Clair WE, Misukonis MA, Weinberg JB. (1998) Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-TNF-alpha monoclonal antibody (cA2). Arthritis. Rheum. In press.
Moilanen E, Moilanen T, Knowles R, et al. (1997) Nitric oxide synthase is expressed in human macrophages during foreign body inflammatory. Am. J. Pathol. 150: 881–887.
Watkins SC, Macaulay W, Turner D, et al. (1997) Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip prostheses. Am. J. Pathol. 150: 1199–1206.
Thomsen LL, Miles DW, Happerfield L, et al. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer 72: 41–44.
Ambs S, Merriam WG, Bennett WP, et al. (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas—implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58: 334–341.
Thomsen LL, Lawton FG, Knowles RG, et al. (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 54: 1352–1354.
Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. (1995) Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55: 727–730.
Anstey NM, Weinberg JB, Hassanali M, et al. (1996) Nitric oxide in Tanzanian children with malaria. Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J. Exp. Med. 184: 557–567.
Furusu A, Miyazaki M, Abe K, et al. (1998) Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int. 53: 1760–1768.
Singer II, Kawka DW, Scott S, et al. (1996) Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 111: 871–885.
Ikeda I, Kasajima T, Ishiyama S, et al. (1997) Distribution of inducible nitric oxide synthase in ulcerative colitis. Am. J. Gastroenterol. 92: 1339–1341.
Mannick EE, Bravo LE, Zarama G, et al. (1996) Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56: 3238–3243.
ter Steege J, Burrman W, Arends JW, Forget P. (1997) Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab. Invest. 77: 29–36.
Bo L, Dawson TM, Wesselingh S, et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36: 778–786.
Bagasra O, Michaels FH, Zheng YM, et al. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 92: 12041–12045.
DeGroot CJA, Ruuls SR, Theeuwes JWM, Dijkstra CD, Vandervalk P. (1997) Immunocyto-chemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56: 10–20.
Hooper DC, Bagasra O, Marini JC, et al. (1997) Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 94: 2528–2533.
Myatt L, Eis ALW, Brockman DE, et al. (1997) Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies. Placenta 18: 261–268.
Zarlingo TJ, Eis ALW, Brockman DE, Kossenjans W, Myatt L. (1997) Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae. Placenta 18: 511–520.
Eis ALW, Brockman DE, Myatt L. (1997) Immu-nolocalization of the inducible nitric oxide synthase isoform in human fetal membranes. Am. J. Reprod. Immunol. 38: 289–294.
Condino-Neto A, Muscara MN, Grumach AS, Carneiro-Sampaio MM, De Nucci G. (1993) Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide. Br. J. Clin. Pharmacol. 35: 485–490.
López-Moratalla N, Calleja A, Gonzalez A, et al. (1996) Inducible nitric oxide synthase in monocytes from patients with Graves’ disease. Biochem. Biophys. Res. Commun. 226: 723–729.
Kim C, Schinkel C, Fuchs D, et al. (1995) Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch. Surg. 130: 1330–1336.
Dias-Da-Motta P, Arruda VR, Muscara MN, et al. (1996) The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br. J. Haematol. 93: 333–340.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weinberg, J.B. Nitric Oxide Production and Nitric Oxide Synthase Type 2 Expression by Human Mononuclear Phagocytes: A Review. Mol Med 4, 557–591 (1998). https://doi.org/10.1007/BF03401758
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401758